Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

New York City voters will head to the polls on June 24 to make their choices for already competitive primaries for major seats, including mayor. Here's everything you need to know before you cast ...

Frontotemporal dementia, also known as FTD, is a rare type of dementia. It is thought to account for less than one in 30 dementia cases. Symptoms typically begin between the ages of 45 and 64. However ...

80 patients with sporadic FTD Control group: 124 patients without cognitive impairment or dementia. The FTD patients had a higher prevalence of head injury and metabolic disease than the control group ...